-
Genetic investigations have made considerable progress in identifying mutations associated with familial amyotrophic lateral sclerosis (ALS). The identification of genetic alterations in patients with sporadic ALS, however, has lagged behind. The present study is a major advance in investigating the etiology of ALS.
-
Thymectomy, though widely recommended for the treatment of autoimmune myasthenia gravis, remains a treatment without controlled prospective studies to support its role. Such a trial has been recommended by the American Academy of Neurology and is being developed.
-
Thomson American Health Consultants offers "Extended-use Contraception: What You Should Know About Seasonale and Other Options," a free audio conference on October 9 from 2-3 p.m. ET.
-
In 1597, the herbalist John Gerard reported that an extract of the sage plant, is singularly good for the head and brain and quickeneth the nerves and memory. More than 400 years later, British investigators have put Gerards observation to the test by examining the effects of an essential oil derived from Spanish sage on memory in normal volunteers and patients with Alzheimers disease.
-
The triptan wars are heating up with 7 competitors now on the market all backed by the heaviest of the pharma heavyweights, and clinicians wonder, Which is the best triptan? This study looked at eletriptan response rates in a cohort of migraine patients previously unresponsive or intolerant to sumatriptan.
-
When is it safe to sit behind the wheel if youve just had a seizure? In this time-trend study, an analysis was undertaken to determine if lowering the interval from 12 months to 3, as was done in Arizona, increased motor vehicle accident frequency.
-
In the present article, Thomalla and colleagues report on the predictive value of early perfusion-weighted magnetic resonance imaging and diffusion-weighted magnetic resonance imaging within 6 hours of stroke onset in 37 patients with MCA stroke and a proximal vessel occlusion, either the carotid-T or MCA stem.
-
The FDA has approved vardenafil (LevitraBayer and GlaxoSmithKline) for
the treatment of erectile dysfunction in men. Vardenafil joins
sildenafil (Viagra) as the only 2 drugs approved for this indication in
this country.
-
A Strategy to Reduce Cardiovascular Disease by More Than 80 Percent;
Pearly Penile Papules: Still No Reason for Uneasiness; The Epidemiology
of Major Depressive Disorder; Urinary Tetrahydroaldosterone as a Screen
for Aldosteronism; Finasteride and Prostate Cancer; Impermeable Bed
Covers in Patients with Allergic Rhinitis
-
This study corroborates a few earlier studies indicating that sympathetic vasomotor dysfunction may have a role in MS-related fatigue.
